Atlas Trials

Establishing 18F-PBR06 PET Imaging as a Viable Pharmacodynamic Endpoint in MSA

Clinical trial NCT03033680 · COMPLETED

Trial details

NCT number
NCT03033680
Sponsor
Brigham and Women's Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
MSA
Start date
2017-03-24
Primary completion
2021-01-15
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.